drugset / Trial / NCT03302936

Assessing Pyridium for Post-Sling Urinary Retention

NCT03302936

Phase 4 Completed 98 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupSingle-blindPrevention

Summary

There has been preliminary data showing that pyridium can decrease the risk of difficulty urinating after midurethral sling. This study is designed to have two groups of patients. One group will receive pyridium pre-operatively, while the other group will have routine preoperative care. Both groups will have their bladder tested prior to going home. It will be evaluated if there is a difference in the difficulty to urinate post-operatively in both groups.

Timeline

Start
2017-10-24
Primary completion
2019-07-01
Completion
2019-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenazopyridine Small molecule 200 mg